68047-06-3
68047-06-3 结构式
基本信息
4-羟基他莫昔芬
(Z)-4-羟基三苯氧胺
4-羟基三苯氧胺 10MG
4-羟基三苯氧胺(Z异构体)
4-羟基三苯氧胺(Z异构体和E
4-羟基三苯氧胺(Z异构体≥7
4-羟基三苯氧胺(Z异构体≥70%)
4-羟基三苯氧胺(Z异构体和E异构体)
(Z)-4-(1-[4-(二甲氨基乙氧基)苯基]-2-苯基-1-丁烯基)苯酚
C05011
ici79,280
(Z)-4-OHT
hydroxytamoxifen
4-HYDROXYTAMOXIFEN
TAMOXIFEN, 4-HYDROXY-
cis-4-Hydroxytamoxifen
trans-4-Hydroxytamoxifen
See H9711, H9712, or H9716
物理化学性质
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/01/25 | HY-16950 | 4-羟基三苯氧胺 4-Hydroxytamoxifen | 68047-06-3 | 10mM * 1mLin DMSO | 639元 |
| 2024/01/25 | HY-16950 | 4-羟基三苯氧胺 4-Hydroxytamoxifen | 68047-06-3 | 5 mg | 750元 |
| 2024/01/25 | HY-16950 | 4-羟基三苯氧胺 4-Hydroxytamoxifen | 68047-06-3 | 10mg | 950元 |
常见问题列表
|
Estrogen receptor 3.3 nM (IC 50 ) |
CRISPR/Cas9
|
4-Hydroxytamoxifen (Monohydroxytamoxifen) is a selective oestrogen receptor antagonist, with an IC 50 of 3.3 nM for the [ 3 H]oestradiol binding to oestrogen receptor. 4-Hydroxytamoxifen (10, 100 nM) enables to inhibit the binding of [ 3 H]oestradiol to the human 8 S oestrogen receptor. 4-Hydroxytamoxifen activates intein-linked inactive Cas9, reduces off-target CRISPR-mediated gene editing. In human cells, conditionally active Cas9s modify target genomic sites with up to 25-fold higher specificity than wild-type Cas9.
4-Hydroxytamoxifen (0.2, 1 and 5 μg/day, p.o.) causes a dose-related decrease in uterine wet weight of immature rats. 4-Hydroxytamoxifen (6 μg/0.1 mL sesame oil/day, s.c.) effectively attenuates methamphetamine-induced nigrostriatal dopamine depletions in bothsexes of intact and gonadectomized C57BL/6 J mice. 4-Hydroxytamoxifen does not alter the dopamine content levels in the striatum.